Table 1.
Demographic information of the patients from the two groups
| Variable | Group A (347) | Group B (671) | P-value |
|---|---|---|---|
| Age (years) | 30.76 ± 2.75 | 30.45 ± 2.58 | 0.064 |
| BMI (kg/m2) | 21.84 ± 3.62 | 21.50 ± 3.38 | 0.136 |
| AFC | 10.50 ± 2.57 | 10.65 ± 2.47 | 0.352 |
| Duration of stimulation (days) | 10.79 ± 1.45 | 10.68 ± 1.44 | 0.230 |
| Total gonadotrophin dose | 2619.95 ± 601.53 | 2685.55 ± 683.73 | 0.116 |
| AMH | 2.58 ± 0.75 | 2.65 ± 0.73 | 0.119 |
| Basal FSH | 7.45 ± 1.39 | 7.39 ± 1.36 | 0.550 |
| Basal E2 | 40.16 ± 29.17 | 40.41 ± 31.72 | 0.900 |
| Basal P | 0.58 ± 0.50 | 0.64 ± 0.92 | 0.276 |
| Number of abortions | 0.45 ± 0.82 | 0.44 ± 0.74 | 0.936 |
| Infertility type | 0.981 | ||
| Primary infertility | 45.53% (158/347) | 45.45% (305/671) | |
| Secondary infertility | 54.47% (189/347) | 54.55% (366/671) | |
| Stimulation protocols | 0.495 | ||
| Antagonist protocol | 25.94% (90/347) | 23.99% (161/671) | |
| Agonist protocol | 74.06% (257/347) | 76.01% (510/671) | |
| Endometrium the day of the hCG trigger | 10.56 ± 2.19 | 10.78 ± 2.24 | 0.129 |
Abbreviations: hCG, human chorionic gonadotropin; E2, estrogen; P, progesterone; AMH, anti-Müllerian hormone: BMI, body mass index; FSH, follicle-stimulating hormone. AFC: Antral Follicle Counting